Literature DB >> 30415445

Spatiotemporal Expression Changes of PACAP and Its Receptors in Retinal Ganglion Cells After Optic Nerve Crush.

Dan Ye1, Yao Yang1, Xi Lu1, Yue Xu1, Yuxun Shi1, Hailiu Chen1, Jingjing Huang2.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) has been demonstrated to play a crucial part in protecting retinal ganglion cells (RGCs) from apoptosis in various retinal injury animal models. PACAP has two basic groups of receptors: PACAP receptor type 1 (PAC1R) and vasoactive intestinal polypeptide/PACAP receptors (VPAC1R and VPAC2R). However, few studies illustrated the spatial and temporal expression changes of endogenous PACAP and its receptors in a rodent optic nerve crush (ONC) model. In this study, a significant upregulation of PACAP and PAC1R in the retina after ONC was observed in both protein and RNA levels. The peak level of PACAP and PAC1R expression could be found on the fifth day following ONC. In addition, immunofluorescent labeling indicated that PACAP and PAC1R were localized mainly in RGCs. On the contrary, VPAC1R and VPAC2R were hardly detected in the retina. Collectively, the spatiotemporal expression of PACAP and its high-affinity receptor PAC1R were remarkably changed after ONC, and mainly expressed in the ganglion cell layer of the retina. This suggested that the upregulation of PACAP and PAC1R may play a vital role in RGC death after ONC.

Entities:  

Keywords:  Optic nerve crush; PACAP; Rat; Receptors; Retinal ganglion cells

Year:  2018        PMID: 30415445     DOI: 10.1007/s12031-018-1203-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  7 in total

Review 1.  The Neuroprotective and Biomarker Potential of PACAP in Human Traumatic Brain Injury.

Authors:  Denes Toth; Andrea Tamas; Dora Reglodi
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

2.  Occurrence of Oxidative Stress and Premature Senescence in the Anterior Segment of Acute Primary Angle-Closure Eyes.

Authors:  Dan Ye; Yue Xu; Yuxun Shi; Jianping Ji; Xi Lu; Hailiu Chen; Rong Huang; Peng Lu; Yunxuan Li; Lu Cheng; Yangyunhui Li; Kaixuan Cui; Xiaoyu Tang; Lixia Luo; Jingjing Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

3.  Adult Expression of Tbr2 Is Required for the Maintenance but Not Survival of Intrinsically Photosensitive Retinal Ganglion Cells.

Authors:  Sadaf Abed; Andreea Reilly; Sebastian J Arnold; David A Feldheim
Journal:  Front Cell Neurosci       Date:  2022-03-23       Impact factor: 6.147

4.  Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice.

Authors:  Peng Lu; Yuxun Shi; Dan Ye; Xi Lu; Xiaoyu Tang; Lu Cheng; Yue Xu; Jingjing Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

5.  Down Syndrome Critical Region 1 Reduces Oxidative Stress-Induced Retinal Ganglion Cells Apoptosis via CREB-Bcl-2 Pathway.

Authors:  Yuxun Shi; Dan Ye; Rong Huang; Yue Xu; Peng Lu; Hailiu Chen; Jingjing Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

6.  Stability Test of PACAP in Eye Drops.

Authors:  Anita K Kovacs; Tamas Atlasz; Dora Werling; Edina Szabo; Dora Reglodi; Gabor K Toth
Journal:  J Mol Neurosci       Date:  2020-04-22       Impact factor: 3.444

Review 7.  Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease.

Authors:  Takahiro Hirabayashi; Junko Shibato; Ai Kimura; Michio Yamashita; Fumiko Takenoya; Seiji Shioda
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.